Brilliant Violet 785™ anti-human CD86 Antibody, CD86, W17233E,BioLegend,381011

Host

Rat

Reactivity

Human

Application

FC - Quality tested

Platform ID

BAB393134407

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameBrilliant Violet 785™ anti-human CD86 Antibody, CD86, W17233E
Cat. No.381011
HostRat
RRIDAB_3097327 (BioLegend Cat. No. 381011)AB_3097327 (BioLegend Cat. No. 381012)
IsotypeRat IgG2b, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityMonoclonal
Clone NumberW17233E
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetCD86
ImmunogenhCD86 Recombinant protein (full)
PurityThe antibody was purified by affinity chromatography and conjugated with Brilliant Violet 785™ under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD86, also known as B7-2, B70, and Ly-58, is an 80 kD immunoglobulin superfamily member. CD86 is expressed on activated B and T cells, monocytes/macrophages, dendritic cells, and astrocytes. CD86, along with CD80, is the ligand of CD28 and CD152 (CTLA-4). CD86 is expressed earlier in the immune response than CD80. CD86 has also been shown to be involved in immunoglobulin class-switching and triggering of NK cell-mediated cytotoxicity. CD86 binds to CD28 to transduce costimulatory signals for T cell activation, proliferation, and cytokine production. CD86 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.